Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration

Dementia and Geriatric Cognitive Disorders
A Kurz, B Van Baelen

Abstract

Data were derived from the Cochrane Collaboration meta-analyses of the efficacies of ginkgo, donepezil, rivastigmine and galantamine on changes in cognitive function in patients with dementia and, where necessary, were transformed to standardized mean differences. The proportion of patients discontinuing trials was used as a proxy measure of tolerability. Outcomes were assessed after 6 months of treatment. Trial data for cholinesterase inhibitors were more consistent than those for ginkgo, particularly regarding patient populations and outcome measures. Significant benefits on cognition vs. placebo were seen with donepezil, 5 and 10 mg, rivastigmine, 6-12 mg, and galantamine, 16 and 24 mg. Significant benefit vs. placebo with ginkgo was seen only when all doses were pooled. Similar proportions of patients discontinued treatment with ginkgo and placebo. Cholinesterase inhibitors were also well tolerated, although a significantly greater proportion of patients receiving active treatment discontinued vs. placebo with some doses. An evidence-based medicine approach, taking into account the quality of clinical trials, is essential when assessing the safety and efficacy of medications.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Oct 29, 1997·JAMA : the Journal of the American Medical Association·P L Le BarsA F Schatzberg
Feb 3, 1998·Journal of Psychiatric Research·K MaurerL Frölich
May 15, 1998·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·H C Hendrie
Apr 24, 1999·BMJ : British Medical Journal·T Bayer
May 15, 1999·Dementia and Geriatric Cognitive Disorders·A BurnsL T Friedhoff
May 5, 2000·The Cochrane Database of Systematic Reviews·S Birks J, D Melzer
Oct 18, 2000·The Cochrane Database of Systematic Reviews·J S BirksH Beppu
Mar 10, 2001·Antioxidants & Redox Signaling·T YoshikawaM Kondo
Aug 29, 2001·Neurology·H FeldmanUNKNOWN Donepezil MSAD Study Investigators Group
Oct 24, 2002·International Journal of Technology Assessment in Health Care·Andrew CleggNorman Waugh
Dec 14, 2002·Annals of the New York Academy of Sciences·John Stirling MeyerMinh Quach
Jan 10, 2003·The Cochrane Database of Systematic Reviews·J BirksM Van Dongen
Aug 15, 2003·The Cochrane Database of Systematic Reviews·J S Birks, R Harvey
Dec 1, 1998·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·M R BrautigamJ Kleijnen

❮ Previous
Next ❯

Citations

Jun 5, 2010·Acta Pharmacologica Sinica·Ying WangHai-yan Zhang
Nov 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·R Overshott, A Burns
May 1, 2009·Therapeutic Advances in Neurological Disorders·Krista L LanctôtNathan Herrmann
May 2, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Kenneth Rockwood
Jan 27, 2011·The Journal of Nutrition, Health & Aging·Antoine PiauB Vellas
Apr 1, 2003·Current Therapeutic Research, Clinical and Experimental·George T Grossberg
Aug 27, 2005·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·R Hoerr
Dec 13, 2016·Journal of Ethnopharmacology·Qiuju YuanZhi-Xiu Lin
Apr 26, 2006·American Journal of Alzheimer's Disease and Other Dementias·Shahin Akhondzadeh, Seyed Hesameddin Abbasi
Jul 30, 2005·World Journal of Gastroenterology : WJG·Shan-Zhi GuBo-Rong Pan
Aug 16, 2006·Phytotherapy Research : PTR·Vikas Kumar
Jun 18, 2010·CNS Neuroscience & Therapeutics·Deepak Sachdeva, Alistair Burns
Jul 12, 2005·CNS Drug Reviews·Bengt Winblad
Feb 19, 2011·BMC Health Services Research·Christopher PearceMarjan Kljakovic
Oct 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·David B HoganLilian Thorpe
Jan 10, 2017·Frontiers in Aging Neuroscience·Blanka Klimova
May 18, 2021·Expert Opinion on Drug Metabolism & Toxicology·Miloš Mitić, Tamara Lazarević-Pašti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.